Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Investing.com - Truist Securities has reiterated its Buy rating on Manhattan Associates, Inc. (NASDAQ:MANH) with a price target of $230.00 ahead of the company’s third-quarter earnings report. According to InvestingPro data, the company maintains a "GOOD" overall financial health score, with 6 analysts recently revising their earnings estimates upward for the upcoming period.
The firm expects Manhattan Associates to deliver "solid" third-quarter results when it reports next Tuesday after market close, with potential upside to consensus estimates in key areas including cloud subscription revenue, total revenue, non-GAAP operating profit, and earnings per share. The company has demonstrated strong operational efficiency with a 56.28% gross margin and impressive returns on equity of 85%.
While the third quarter can typically be less predictable or seasonally slower for cloud bookings, Truist anticipates the company will outperform Street expectations in this metric as well.
Truist notes that investor focus will likely shift to fourth-quarter 2025 performance and the level of seasonal strength in cloud bookings, along with emerging growth drivers that could support sustained cloud subscription revenue growth exceeding 20% in 2026 and beyond.
The firm’s continued Buy rating is based on Manhattan Associates’ sustained cloud subscription revenue growth, strategies being implemented to maximize the cloud innovation cycle, and top-quartile earnings per share and cash flow performance.
In other recent news, Manhattan Associates Inc. reported impressive financial results for the second quarter of 2025, surpassing analyst expectations. The company achieved an adjusted earnings per share (EPS) of $1.31, exceeding the forecasted $1.13. Revenue also outperformed projections, reaching $272 million compared to the expected $263.64 million. Following these results, DA Davidson raised its price target for Manhattan Associates to $250 while maintaining a Buy rating, citing the company’s strong financial performance driven by new logo wins and disciplined expense management. Stifel also initiated coverage of the company with a Buy rating and a price target of $250, reflecting confidence in Manhattan Associates’ fiscal year 2027 free cash flow estimate. Additionally, Truist Securities reiterated its Buy rating and $230 price target, emphasizing the company’s commitment to robust cloud subscription revenue growth through strategic investments and platform innovation. These developments highlight the positive outlook from multiple analyst firms on Manhattan Associates’ future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.